Physician profile
Robert Fromuth
NPI 1902219215
$858.78
in general payments reported to CMS, 2019-2025
8 companies · $209 in 2025
The $209 reported for 2025 was more than what 76% of General Practice (Dentist) providers received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $88.27 · 2021: $133 · 2022: $28.21 · 2023: $363 · 2024: $36.94 · 2025: $209.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $334 · Education: $275.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $334.41 |
| Education | $275.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Align Technology, INC. | $288.41 | 2023-2025 | Itero Element 5d Plus, Invisalign |
| Zimvie INC. | $250.00 | 2023-2025 | |
| Dentsply Sirona INC | $147.21 | 2021-2022 | |
| Straumann USA LLC | $72.28 | 2019 | |
| Voco America INC. | $38.01 | 2024-2025 | Voco Profluorid Varnish, Provicol Qm Aesthetic, Admira Fusion X-Tra |
| Philips North America LLC | $31.03 | 2021-2025 | Oral Health Care Undivided |
| 3m Company | $15.99 | 2019 | |
| Solventum Corporation | $15.85 | 2024 | 3m Scotchbond, Vanish, Clinpro 5000 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Fromuth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.